ArticleDisease markers2022

miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.

Shusen Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.